Literature DB >> 23012201

SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA.

Ayman K Johargy1.   

Abstract

OBJECTIVES: To determine the seroprevalence of immunoglobulin G (IgG) to erythrovirus B19 in Saudi blood donors in Makkah. Saudi Arabia. SUBJECTS AND METHODS: A total of 578 blood (serum) samples were tested for erythrovirus B19-specific-IgG antibody among Saudi blood donors in Makkah. Saudi Arabia.
RESULTS: Erythrovirus B19-specific-IgG antibodies were detected in 441/578 (76.3%) of Saudi blood donors of different age groups.
CONCLUSION: This study indicated that 76.3% of Saudi blood donors in Makkah city, Saudi Arabia, had been exposed to erythrovirus B19. This result is in accordance with previous studies performed in other countries.

Entities:  

Keywords:  ELISA; Makkah; Saudi Arabia; blood donors; erythrovirus B19

Year:  2009        PMID: 23012201      PMCID: PMC3377043     

Source DB:  PubMed          Journal:  J Family Community Med        ISSN: 1319-1683


  21 in total

Review 1.  The transfusion-associated transmission of parvovirus B19.

Authors:  A Azzi; M Morfini; P M Mannucci
Journal:  Transfus Med Rev       Date:  1999-07

2.  Parvovirus B19: a cause for aplastic crisis and hemophagocytic lymphohistiocytosis.

Authors:  S Yilmaz; H Oren; F Demircioğlu; F Firinci; A Korkmaz; G Irken
Journal:  Pediatr Blood Cancer       Date:  2006-11       Impact factor: 3.167

3.  The prevalence of antibody to human parvovirus B19 in England and Wales.

Authors:  B J Cohen; M M Buckley
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

4.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

5.  Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.

Authors:  Nikos Papadogiannakis; Thomas Tolfvenstam; Björn Fischler; Oscar Norbeck; Kristina Broliden
Journal:  Clin Infect Dis       Date:  2002-10-11       Impact factor: 9.079

6.  Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission.

Authors:  M Letaïef; G Vanham; K Boukef; S Yacoub; L Muylle; G Mertens
Journal:  Transfus Sci       Date:  1997-12

7.  Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma.

Authors:  U F Koenigbauer; T Eastlund; J W Day
Journal:  Transfusion       Date:  2000-10       Impact factor: 3.157

8.  A novel protein encoded by small RNAs of parvovirus B19.

Authors:  W Luo; C R Astell
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

Review 9.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Human parvovirus B19 infection in blood donors.

Authors:  M Tsujimura; K Matsushita; H Shiraki; H Sato; K Okochi; Y Maeda
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

View more
  3 in total

Review 1.  Molecular and serological markers of human parvovirus B19 infection in blood donors: A systematic review and meta-analysis.

Authors:  Mohammad Farahmand; Ahmad Tavakoli; Saied Ghorbani; Seyed Hamidreza Monavari; Seyed Jalal Kiani; Sara Minaeian
Journal:  Asian J Transfus Sci       Date:  2021-11-01

2.  Seroprevalence of erythrovirus B19 in Saudi pregnant women.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2016 May-Aug

3.  Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.

Authors:  Doua Abdelrahman; Duaa W Al-Sadeq; Maria K Smatti; Sara A Taleb; Raed O AbuOdeh; Enas S Al-Absi; Asmaa A Al-Thani; Peter V Coyle; Nader Al-Dewik; Ahmed A Al Qahtani; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.